These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Search for effective short-course regimens for the treatment of leprosy. Pattyn SR Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183 [No Abstract] [Full Text] [Related]
24. Initial diagnosis of leprosy in patients treated by an ophthalmologist and confirmation by conventional analysis and polymerase chain reaction. Chaudhry IA; Shamsi FA; Elzaridi E; Awad A; Al-Fraikh H; Al-Amry M; Al-Dhibi H; Riley FC Ophthalmology; 2007 Oct; 114(10):1904-11. PubMed ID: 17532046 [TBL] [Abstract][Full Text] [Related]
25. Reverse line probe assay for the rapid detection of rifampicin resistance in Mycobacterium leprae. Sapkota BR; Ranjit C; Macdonald M Nepal Med Coll J; 2006 Jun; 8(2):122-7. PubMed ID: 17017404 [TBL] [Abstract][Full Text] [Related]
26. A method for rapid detection of rifampicin-resistant isolates of Mycobacterium leprae. Honoré N; Roche PW; Grosset JH; Cole ST Lepr Rev; 2001 Dec; 72(4):441-8. PubMed ID: 11826480 [TBL] [Abstract][Full Text] [Related]
27. An update on the diagnosis and treatment of leprosy. Moschella SL J Am Acad Dermatol; 2004 Sep; 51(3):417-26. PubMed ID: 15337986 [No Abstract] [Full Text] [Related]
28. Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood of individuals, eight years after completion of anti-leprosy therapy. Santos AR; Balassiano V; Oliveira ML; Pereira MA; Santos PB; Degrave WM; Suffys PN Mem Inst Oswaldo Cruz; 2001 Nov; 96(8):1129-33. PubMed ID: 11784934 [TBL] [Abstract][Full Text] [Related]
29. Mycobacterium leprae particle agglutination in diagnosis and monitoring of treatment of leprosy. Kampirapap K J Med Assoc Thai; 1999 Oct; 82(10):1020-4. PubMed ID: 10561966 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of 85 A-C intergenic region PCR primers for detection of Mycobacterium leprae DNA in urine samples. Caleffi KR; Hirata RD; Hirata MH; Caleffi ER; Peixoto PR; Sposito FL; Cardoso RF Int J Dermatol; 2010 Jun; 49(6):717-8. PubMed ID: 20618483 [No Abstract] [Full Text] [Related]
31. [Drug resistance of Mycobacterium leprae]. Pattyn SR Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466 [No Abstract] [Full Text] [Related]
32. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea. You EY; Kang TJ; Kim SK; Lee SB; Chae GT J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834 [TBL] [Abstract][Full Text] [Related]
34. An approach to understanding the transmission of Mycobacterium leprae using molecular and immunological methods: results from the MILEP2 study. Smith WC; Smith CM; Cree IA; Jadhav RS; Macdonald M; Edward VK; Oskam L; van Beers S; Klatser P Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):269-77. PubMed ID: 15485283 [TBL] [Abstract][Full Text] [Related]
35. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs. Almeida JG Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367 [No Abstract] [Full Text] [Related]
36. Recent advances in the microbiology of leprosy. Katoch VM; Sharma VD Indian J Lepr; 2000; 72(3):363-79. PubMed ID: 11105277 [No Abstract] [Full Text] [Related]
39. Comment: Persistence of Mycobacterium leprae in the peripheral nerves of multidrug-treated leprosy patients. Grange JM; Beck JS; Abbot NC Lepr Rev; 1993 Sep; 64(3):280. PubMed ID: 8110236 [No Abstract] [Full Text] [Related]
40. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines. Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]